Lazard Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,744	Closed	-$13K	–	2063
2025 Q2	$13K	Sell	7,744 -13,946	-64%	-$34.7K	﹤0.01%	2150
2025 Q1	$72K	Buy	21,690 +21,625	+33,269%	+$112K	﹤0.01%	1905
2024 Q4	$0	Hold	65	–	–	﹤0.01%	2403
2024 Q3	$0	Sell	65 -161	-71%	-$1.52K	﹤0.01%	2360
2024 Q2	$1K	Sell	226 -3,642	-94%	-$39K	﹤0.01%	2152
2024 Q1	$56K	Sell	3,868 -2,133	-36%	-$24.8K	﹤0.01%	1699
2023 Q4	$48K	Buy	6,001 +2,320	+63%	+$12.1K	﹤0.01%	1894
2023 Q3	$16K	Buy	3,681 +146	+4%	+$953	﹤0.01%	2121
2023 Q2	$24K	Buy	3,535 +114	+3%	+$816	﹤0.01%	2068
2023 Q1	$20K	Buy	3,421 +699	+26%	+$4.82K	﹤0.01%	2055
2022 Q4	$17K	Sell	2,722 -770	-22%	-$6.01K	﹤0.01%	2152
2022 Q3	$32K	Buy	3,492 +18	+0.5%	+$208	﹤0.01%	1968
2022 Q2	$37K	Buy	3,474 +117	+3%	+$1.53K	﹤0.01%	1939
2022 Q1	$55K	Buy	3,357 +934	+39%	+$14.4K	﹤0.01%	1695
2021 Q4	$46K	Buy	2,423 +425	+21%	+$9.36K	﹤0.01%	1777
2021 Q3	$48K	Sell	1,998 -1,008	-34%	-$23.8K	﹤0.01%	1699
2021 Q2	$77K	Buy	3,006 +2,945	+4,828%	+$76.5K	﹤0.01%	1424
2021 Q1	$1K	Hold	61	–	–	﹤0.01%	1826
2020 Q4	$2K	Buy	+61	New	+$2.42K	﹤0.01%	1806